Pre-market top loser: JEN.SW Jenoptik (SIX) -47% CHF19.49 Feb 2026: catalysts
JEN.SW stock drops to CHF19.49 pre-market; analysis of drivers, valuation and Meyka AI forecast
JEN.SW stock drops to CHF19.49 pre-market; analysis of drivers, valuation and Meyka AI forecast
5658.T stock jumps on a 15.48x volume spike intraday; price ¥388.00. Meyka AI forecast sees near-term upside to ¥405.17.
Intraday: 1370.HK stock falls 15% to HK$0.255 on 04 Feb 2026. Outlook, Meyka grade, forecast and price targets.
Pre-market: 2PP.DE stock drops 20.28% to €35.74 on XETRA; analysis, grade and Meyka AI forecast
Novo Nordisk stock slides after guiding 2026 sales and operating profit down 5-13% on US pricing pressure and looming semaglutide LOE. UK investors: key risks, Wegovy sales outlook, Eli Lilly rivalry,
OWLI.CN stock jumps 25% on 04 Feb 2026; we analyze drivers, valuation, Meyka AI forecast and price targets
Intraday report on AQI.AX stock at A$2.10 on 04 Feb 2026; volume spike, technicals, Meyka AI forecast and price targets
Marius Borg Hoiby trial opens in Oslo as new arrest and Epstein emails intensify scrutiny of Norway’s monarchy. We assess ESG and governance risk for German investors and why policy risk looks limited
LTNC stock trades at USD 0.0003 on heavy volume; analysis, Meyka grade, and forecast for investors
Leerink maintains Outperform on MDT Feb 03, 2026. MDT analyst rating maintained, implications, market context, Meyka B+.